Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.49−0.06 (-3.87%)
Close on Nov 12, 2026Market cap $1.95MP/E –Yield –
Can-Fite BioPharma operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was -2456.8%, against -1206.2% the year before. The highest annual figure on record is -141.7% in fiscal 2018.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2456.8% | −1250.6 |
| FY2024 | Dec 31, 2024 | -1206.2% | −103.3 |
| FY2023 | Dec 31, 2023 | -1103.0% | +143.5 |
| FY2022 | Dec 31, 2022 | -1246.4% | +259.1 |
| FY2021 | Dec 31, 2021 | -1505.5% | +347.6 |
| FY2020 | Dec 31, 2020 | -1853.1% | −1262.2 |
| FY2019 | Dec 31, 2019 | -590.9% | −449.2 |
| FY2018 | Dec 31, 2018 | -141.7% | +768.9 |
| FY2017 | Dec 31, 2017 | -910.6% | +4351.8 |
| FY2016 | Dec 31, 2016 | -5262.4% | −1264.3 |
| FY2015 | Dec 31, 2015 | -3998.1% | – |
See a number that looks wrong?